Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease
Abstract Revascularization surgery is considered a standard treatment for preventing additional stroke in symptomatic moyamoya disease (MMD). In hemodynamically stable, and asymptomatic or mildly symptomatic patients, however, the treatment strategy is controversial because of the obscure natural co...
Enregistré dans:
Auteurs principaux: | Chang Hwan Pang, Won-Sang Cho, Hyun-Seung Kang, Jeong Eun Kim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fd256a1518764bd19fecd83a1e8300f6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome
par: Kaijiang Kang, et autres
Publié: (2017) -
Long-term cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease
par: Shun Uchida, et autres
Publié: (2021) -
Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
par: Brandon M. Fox, et autres
Publié: (2021) -
Serum miRNA signature in Moyamoya disease.
par: Dongwei Dai, et autres
Publié: (2014) -
Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients
par: Jie Xu, et autres
Publié: (2017)